Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -143.29%-478.75K | 95.03%-17.8K | -128.12%-451.54K | 29.28%-1.31M | -30.21%-561.33K | 72.50%-196.78K | -107.54%-358.11K | 63.27%-197.94K | 16.58%-1.86M | -118.46%-431.11K |
| Net income from continuing operations | 55.69%-402.1K | 86.69%-718.54K | -135.60%-721.75K | -272.57%-7.15M | -15.90%-537.97K | -57.93%-907.5K | -1,380.88%-5.4M | 40.59%-306.34K | 63.39%-1.92M | 77.55%-464.16K |
| Operating gains losses | -1,248.97%-14.99K | 146.49%13.39K | -776.17%-6.21K | -1,248.14%-70.14K | -739.05%-43.55K | 4.99%1.31K | -146.98%-28.81K | 101.45%919 | -16.05%6.11K | 104.92%6.82K |
| Depreciation and amortization | -7.33%10.17K | -49.47%14.82K | 168.18%20.04K | 48.60%58.94K | 19.48%11.17K | -16.46%10.98K | 315.46%29.33K | -26.19%7.47K | 123.32%39.67K | 108.08%9.35K |
| Asset impairment expenditure | --0 | ---- | ---- | --5.13M | --0 | --0 | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | -56.96%208.19K | --231.27K | 6,284.54%532.15K | 261.51%612.23K | 604.16%120.14K | 2,735.46%483.76K | --0 | -92.96%8.34K | -89.36%169.35K | -46.56%17.06K |
| Other non cashItems | 221.62%2.14K | -4.10%819 | -73.62%273 | -17.34%2.56K | --0 | --666 | --854 | --1.04K | --3.09K | ---- |
| Change In working capital | -231.84%-282.15K | 556.65%440.44K | -404.54%-276.03K | 161.67%97.09K | -3,299.08%-111.12K | 224.07%214.02K | -190.41%-96.45K | 202.58%90.64K | -9.40%-157.43K | -100.76%-3.27K |
| -Change in receivables | -208.29%-126.73K | -505.66%-57.41K | -184.81%-16.64K | 401.03%123.47K | 65.20%-27.34K | 253.12%117.03K | -86.65%14.15K | 146.61%19.62K | 66.30%-41.02K | -206.59%-78.57K |
| -Change in prepaid assets | --0 | --0 | --19.97K | -215.14%-19.97K | -115.69%-19.97K | --0 | --0 | --0 | 224.22%17.34K | 984.76%127.24K |
| -Change in payables and accrued expense | -260.25%-155.42K | 550.12%497.85K | -493.36%-279.36K | 95.21%-6.41K | -22.85%-63.81K | 1,196.04%96.98K | -1,889.69%-110.6K | 174.38%71.02K | -1,522.11%-133.76K | -111.04%-51.94K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -143.29%-478.75K | 95.03%-17.8K | -128.12%-451.54K | 29.28%-1.31M | -30.21%-561.33K | 72.50%-196.78K | -107.54%-358.11K | 63.27%-197.94K | 16.58%-1.86M | -118.46%-431.11K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6.42%-518.04K | -236.31%-1.24M | -30.49%-256.97K | -67.26%-2.31M | -489.88%-1.26M | -407.36%-486.81K | 3.33%-369.03K | 71.44%-196.93K | 73.69%-1.38M | 88.11%-212.82K |
| Net PPE purchase and sale | -6.42%-518.04K | -236.31%-1.24M | -30.49%-256.97K | -64.28%-2.31M | -489.88%-1.26M | -302.49%-486.81K | 3.33%-369.03K | 71.44%-196.93K | 73.22%-1.4M | 88.11%-212.82K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6.42%-518.04K | -236.31%-1.24M | -30.49%-256.97K | -67.26%-2.31M | -489.88%-1.26M | -407.36%-486.81K | 3.33%-369.03K | 71.44%-196.93K | 73.69%-1.38M | 88.11%-212.82K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 229.05%10.34M | 1,493.37%266.92K | 10,027.70%812.88K | 5.82%3.58M | 1,497.18%433.1K | 19.74%3.14M | 16.75K | -101.03%-8.19K | 370.38%3.39M | -104.31%-31K |
| Net issuance payments of debt | -37.87%-11.54K | 32.36%-5.58K | -2.22%-8.37K | 49.48%-24.81K | 100.00%-1 | ---8.37K | ---8.25K | ---8.19K | ---49.11K | ---49.11K |
| Net common stock issuance | ---- | ---- | ---- | -11.33%3.26M | --0 | 14.28%3.26M | --0 | --0 | --3.68M | --0 |
| Proceeds from stock option exercised by employees | --4.31M | 990.00%272.5K | --821.25K | --477.5K | --452.5K | --0 | --25K | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | 45.69%-133.57K | -207.15%-19.4K | ---- | ---- | ---- | -134.16%-245.94K | --18.11K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 229.05%10.34M | 1,493.37%266.92K | 10,027.70%812.88K | 5.82%3.58M | 1,497.18%433.1K | 19.74%3.14M | --16.75K | -101.03%-8.19K | 370.38%3.39M | -104.31%-31K |
| Net cash flow | ||||||||||
| Beginning cash position | 162.96%302.39K | 56.82%1.29M | -3.13%1.19M | 13.76%1.23M | 35.21%2.57M | 26.72%114.99K | 27.96%825.38K | 13.76%1.23M | -86.21%1.08M | -18.91%1.9M |
| Current changes in cash | 280.00%9.34M | -39.64%-991.97K | 125.90%104.38K | -125.87%-38.44K | -105.00%-1.38M | 35.64%2.46M | -28.17%-710.38K | 7.31%-403.05K | 102.20%148.58K | 46.75%-674.93K |
| End cash Position | 274.77%9.65M | 162.96%302.39K | 56.82%1.29M | -3.13%1.19M | -3.13%1.19M | 35.21%2.57M | 26.72%114.99K | 27.96%825.38K | 13.76%1.23M | 13.76%1.23M |
| Free cash from | -45.82%-996.79K | -73.13%-1.26M | -79.43%-708.51K | -11.01%-3.62M | -182.13%-1.82M | 18.29%-683.59K | -31.19%-727.14K | 67.85%-394.86K | 56.33%-3.26M | 67.60%-643.93K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.